Evidence map›Paper›PMID 31280299›Full record

ArticleEuropean journal of public health2019

Women's excess unhealthy life years: disentangling the unhealthy life years gap.

Wilma J Nusselder, Emmanuelle M Cambois, Dagmar Wapperom, France Meslé, Caspar W N Looman, Renata T C Yokota, Herman Van Oyen, Carrol Jagger, Jean Marie Robine

Abstract read
In one paragraph

Article in European journal of public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Microbes Saving Lives and Reducing Suffering.Microbial biotechnology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Gender and palliative care: a call to arms.Palliative care and social practice · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wilma J NusselderDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
Emmanuelle M CamboisINED (French Institute for Demographic Studies), Mortality, Health, Epidemiology Research Unit, Paris, France.
Dagmar WapperomDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
France MesléINED (French Institute for Demographic Studies), Mortality, Health, Epidemiology Research Unit, Paris, France.
Caspar W N LoomanDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
Renata T C YokotaSD Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Herman Van OyenSD Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Carrol JaggerInstiute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
Jean Marie RobineInserm (French Institute of Health and Medical Research), CERMES3 Research Unit, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCompared to men, women live longer but have more years with disability. We assessed the contribution of gender differences in mortality and disability, total and by cause, to women's excess unhealthy life years (ULYs).

methodsWe used mortality data for France 2008 from Eurostat, causes of death from the CépiDc-INSERM-database; and disability and chronic conditions data from the French Disability Health Survey 2008-09. ULYs were calculated by the Sullivan method. The contributions of mortality and disability differences to gender differences in ULY were based on decomposition analyses.

resultsLife expectancy of French women aged 50 was 36.3 years of which 19.0 were ULYs; life expectancy of men was 30.4 years of which 14.2 were ULYs. Of the 4.8 excess ULYs in women, 4.0 years were due to lower mortality. Of these 4.0 ULYs, 1.8 ULY originated from women's lower mortality from cancer, 0.8 ULY from heart disease and 0.3 ULY from accidents. The remaining 0.8 excess ULY in women were from higher disability prevalence, including higher disability from musculoskeletal diseases (+1.8 ULY) and anxiety-depression (+0.6 ULY) partly offset by lower disability from heart diseases (-0.8 ULY) and accidents (-0.3 ULY).

conclusionLower mortality and higher disability prevalence contributed to women's longer life expectancy with disability. Women's higher disability prevalence due to non-fatal disabling conditions was partly offset by lower disability from heart disease and accidents. Conditions differentially impact gender differences in ULY, depending on whether they are mainly life-threatening or disabling. The conclusions confirm the health-survival paradox.

Indexed as

Health StatusLife ExpectancyWomenAgedAged, 80 and overAge FactorsCause of DeathFemaleFranceHealth SurveysHumansMaleMiddle AgedMortalityPersons with DisabilitiesPrevalence

Identifiers

PMID31280299
PMCPMC6761840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.